DHSC_PCP_HPV Self-sampling Cost Effectiveness Model

The UK NSC is looking to appoint a competent supplier to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.

This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample.

Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.

Contract Project Reference: C253383 Title: DHSC_PCP_HPV Self-sampling Cost Effectiveness Model Contract term: 18 months with the option to extend for a period of up to 6 months.

Estimated contract value (including extensions): £250,000 excluding VAT (£300,000 including VAT).

The opportunity is available on the DHSC Atamis eTendering System.

Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.

To find this opportunity in the eTendering system, select "Find Opportunities" and then search by project number or title.

Once you have found the Opportunity, press the 'Register Interest' button to register your interest.

This will make the project to appear on 'My proposals and quotes'.

From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity.

For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.